Global Genomic Urine Testing Industry is anticipated to witness a revenue of US$ 251.4 Million by the year 2033, according to FMI’s forecast
The healthcare landscape is set to undergo a transformative shift with the projected growth of the global genomic urine testing industry. Anticipated to soar from its current valuation of US$ 117.7 million in 2023 to an impressive US$ 251.4 million by 2033, this market is poised for an exponential expansion at a 7.9% Compound Annual…